MMP11 is a regulator of prostate cancer radioresistance and a promising liquid biopsy marker of prostate cancer
Gorodetska, I. Lukiyanchuk, V. Gawin, M. Linge, A. Lohaus, F. Hölscher, T. Erdmann, K. Fuessel, S. Borkowetz, A. Reardon, M.
Gorodetska, I.
Lukiyanchuk, V.
Gawin, M.
Linge, A.
Lohaus, F.
Hölscher, T.
Erdmann, K.
Fuessel, S.
Borkowetz, A.
Reardon, M.
Citations
Altmetric:
Abstract
Authors
Gorodetska, I.
Lukiyanchuk, V.
Gawin, M.
Linge, A.
Lohaus, F.
Hölscher, T.
Erdmann, K.
Fuessel, S.
Borkowetz, A.
Reardon, M.
Choudhury, A.
Antonelli, Y.
Leal-Egana, A.
Köseer, A. S.
Kahya, U.
Püschel, J.
Klusa, D.
Peitzsch, C.
Kronstein-Wiedemann, R.
Tonn, T.
Thomas, C.
Widlak, P.
Pietrowska, M.
Krause, M.
Dubrovsk, A.
Lukiyanchuk, V.
Gawin, M.
Linge, A.
Lohaus, F.
Hölscher, T.
Erdmann, K.
Fuessel, S.
Borkowetz, A.
Reardon, M.
Choudhury, A.
Antonelli, Y.
Leal-Egana, A.
Köseer, A. S.
Kahya, U.
Püschel, J.
Klusa, D.
Peitzsch, C.
Kronstein-Wiedemann, R.
Tonn, T.
Thomas, C.
Widlak, P.
Pietrowska, M.
Krause, M.
Dubrovsk, A.
Description
Date
2025
Publisher
Collections
Keywords
Type
Meetings and Proceedings
Citation
Gorodetska I, Lukiyanchuk V, Gawin M, Linge A, Lohaus F, Hölscher T, et al. MMP11 is a regulator of prostate cancer radioresistance and a promising liquid biopsy marker of prostate cancer. RADIOTHERAPY AND ONCOLOGY. 2025 MAY;206:S3979-S81. PubMed PMID: WOS:001521587100018. English.